immutep (asx:imm, nasdaq:immp) - innovative cancer therapies
Published 2 years ago • 221 plays • Length 4:44
Download video MP4
Download video MP3
Similar videos
-
10:01
immutep limited (asx:imm, nasdaq:immp) encouraging results for immutep's cancer therapies
-
47:53
immutep (asx:imm, nasdaq:immp) tacti-003 results, june 2024
-
6:25
immutep (asx:imm, nasdaq:immp) discusses a transformative year for lag-3 therapies
-
4:40
immutep (asx:imm, nasdaq:immp) announces encouraging trial data for lung cancer therapy
-
7:09
immutep (asx:imm, nasdaq:immp) reports 71.4% response rate for lung cancer therapy, october 31, 2023
-
56:38
immutep (asx:imm, nasdaq:immp) webcast for tacti-002 data presented at asco 2022 - 10 jun 2022
-
6:59
immutep (asx:imm; nasdaq: immp) global leader in development of lag 3 gene immuno-therapies
-
7:17
immutep (asx:imm, nasdaq:immp) delivering strong data in first-line non-small cell lung cancer
-
52:08
immutep (asx:imm, nasdaq:immp) global webcast presentation at sitc 2022
-
7:13
from the helm: immutep's (asx:imm, nasdaq:immp) executive director & ceo marc voigt
-
5:42
immutep (asx:imm, nasdaq:immp) receives fast track designation from fda - october 12, 2022
-
6:03
immutep (asx:imm, nasdaq:immp) reports positive discussions with the fda and strong survival data
-
15:49
immutep (asx:imm) - webinar presentation
-
3:33
immutep (asx:imm) reports positive trial data
-
6:42
immutep (asx:imm, nasdaq:immp) lag-3 validated in bristol myers squibb trial
-
7:58
immutep: a leader in a league alongside global pharma giants
-
50:22
immutep (asx:imm, nasdaq:immp) esmo congress results webinar, 23 october 2023
-
27:17
immutep limited (asx:imm, nasdaq:immp) - fireside chat with immutep limited
Clip.africa.com - Privacy-policy